Benefits and limitations of humanized mice in HIV persistence studies

por Marsden, Matthew D.
Publicado 2020

Activation of Latent HIV Using Drug-Loaded Nanoparticles

por Kovochich, Michael, Marsden, Matthew D., Zack, Jerome A.
Publicado 2011

Contribution of Sex Differences to HIV Immunology, Pathogenesis, and Cure Approaches

por Moran, Jose A., Turner, Shireen R., Marsden, Matthew D.
Publicado 2022

Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversal

por Moran, Jose A., Ranjan, Alok, Hourani, Rami, Kim, Jocelyn T., Wender, Paul A., Zack, Jerome A., Marsden, Matthew D.
Publicado 2023

Designed, Synthetically Accessible Bryostatin Analogues Potently Induce Activation of Latent HIV Reservoirs in vitro

por DeChristopher, Brian A., Loy, Brian A., Marsden, Matthew D., Schrier, Adam J., Zack, Jerome A., Wender, Paul A.
Publicado 2012

RNAi-Mediated CCR5 Knockdown Provides HIV-1 Resistance to Memory T Cells in Humanized BLT Mice

por Shimizu, Saki, Ringpis, Gene-Errol, Marsden, Matthew D, Cortado, Ruth V, Wilhalme, Holly M, Elashoff, David, Zack, Jerome A, Chen, Irvin S Y, An, Dong Sung
Publicado 2015

Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy

por Hardman, Clayton, Ho, Stephen, Shimizu, Akira, Luu-Nguyen, Quang, Sloane, Jack L., Soliman, Mohamed S. A., Marsden, Matthew D., Zack, Jerome A., Wender, Paul A.
Publicado 2020

Tracking HIV Rebound following Latency Reversal Using Barcoded HIV

por Marsden, Matthew D., Zhang, Tian-hao, Du, Yushen, Dimapasoc, Melanie, Soliman, Mohamed S.A., Wu, Xiaomeng, Kim, Jocelyn T., Shimizu, Akira, Schrier, Adam, Wender, Paul A., Sun, Ren, Zack, Jerome A.
Publicado 2020

Bioengineered Vaults: Self-Assembling Protein Shell–Lipophilic Core Nanoparticles for Drug Delivery

por Buehler, Daniel C., Marsden, Matthew D., Shen, Sean, Toso, Daniel B., Wu, Xiaomeng, Loo, Joseph A., Zhou, Z. Hong, Kickhoefer, Valerie A., Wender, Paul A., Zack, Jerome A., Rome, Leonard H.
Publicado 2014

Disruption of Type I Interferon Induction by HIV Infection of T Cells

por Sanchez, David Jesse, Miranda, Daniel, Marsden, Matthew D., Dizon, Thomas Michael A., Bontemps, Johnny R., Davila, Sergio J., Del Mundo, Lara E., Ha, Thai, Senaati, Ashkon, Zack, Jerome A., Cheng, Genhong
Publicado 2015

In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication

por Marsden, Matthew D., Loy, Brian A., Wu, Xiaomeng, Ramirez, Christina M., Schrier, Adam J., Murray, Danielle, Shimizu, Akira, Ryckbosch, Steven M., Near, Katherine E., Chun, Tae-Wook, Wender, Paul A., Zack, Jerome A.
Publicado 2017

Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents

por Marsden, Matthew D., Wu, Xiaomeng, Navab, Sara M., Loy, Brian A., Schrier, Adam J., DeChristopher, Brian A., Shimizu, Akira J., Hardman, Clayton T., Ho, Stephen, Ramirez, Christina M., Wender, Paul A., Zack, Jerome A.
Publicado 2018

Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo

por Pache, Lars, Marsden, Matthew D., Teriete, Peter, Portillo, Alex J., Heimann, Dominik, Kim, Jocelyn T., Soliman, Mohamed S.A., Dimapasoc, Melanie, Carmona, Camille, Celeridad, Maria, Spivak, Adam M., Planelles, Vicente, Cosford, Nicholas D.P., Zack, Jerome A., Chanda, Sumit K.
Publicado 2020

Latency reversal plus natural killer cells diminish HIV reservoir in vivo

por Kim, Jocelyn T., Zhang, Tian-Hao, Carmona, Camille, Lee, Bryanna, Seet, Christopher S., Kostelny, Matthew, Shah, Nisarg, Chen, Hongying, Farrell, Kylie, Soliman, Mohamed S. A., Dimapasoc, Melanie, Sinani, Michelle, Blanco, Kenia Yazmin Reyna, Bojorquez, David, Jiang, Hong, Shi, Yuan, Du, Yushen, Komarova, Natalia L., Wodarz, Dominik, Wender, Paul A., Marsden, Matthew D., Sun, Ren, Zack, Jerome A.
Publicado 2022